anonymous
Guest
anonymous
Guest
Interesting way to look at it. Balance sheet watchers should stand up and ask some tough questions, are these people really needed?
Is there anyone from company with half a brain on this board or just sales reps? Only question is are you going to get approval and good label or are you dopes going to get YET ANOTHER CRL?
Assuming you do get approval, does your commercial leadership have a clue on how to launch this? Right now, the street says no.
Anyone feeling a little nervous? One week away!
Things seem too quiet.
if you follow the fda pdufa calender dates you will see the fda has issued a delay notice for almost ever June pdufa of up to 90 days in order to complete reviews.
Fda issues the delay within 0-5 days of each pdufa date. Find out out this week either way.
i know. Question was people worried about another one. We will know within72
Hours so that’s good.
I just got an offer
PCRX above 70/share, interesting
Pacira has no fear of this company because your management is incompetent and will blow the launch IF you ever get it approved. Thank God I don’t work there!
Seriously one of the worst companies in biopharm. How hard can it be to get a 505 b2 submission approved YEARS after getting great data? Absolute clown show.
There is a definite lack of accountability here. Has anyone ever been fired or is it just Commercial folks leaving on their own because they see the writing on the wall?